J Korean Ophthalmol Soc > Volume 50(9); 2009 > Article
Journal of the Korean Ophthalmological Society 2009;50(9):1404-1408.
DOI: https://doi.org/10.3341/jkos.2009.50.9.1404    Published online September 15, 2009.
Effect of Bevacizumab on Survival and Production of Nitric Oxide in Trabecular Meshwork Cells.
Sin Hoo Kim, Jae Woo Kim
Department of Ophthalmology, Catholic University of Daegu College of Medicine, Daegu, Korea. jwkim@cu.ac.kr
베바시주맙이 섬유주세포의 생존과 일산화질소의 생성에 미치는 영향
김신후ㆍ김재우
Department of Ophthalmology, Catholic University of Daegu College of Medicine, Daegu, Korea
Abstract
PURPOSE
To investigate the effect of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), on the survival and production of nitric oxide (NO) in human trabecular meshwork cells (HTMC). METHODS: Primarily cultured HTMC were exposed to 0, 0.25, 1.0, and 2.5 mg/ml bevacizumab for 24 hours. Cellular survival and production of NO were assessed by MTT assay and Griess assay, respectively. RESULTS: Bevacizumab did not affect the cellular survival at low concentrations but decreased cellular survival significantly at high concentrations (>1.0 mg/ml) accompanied with increased NO production. CONCLUSIONS: High concentrations of bevacizumab may be toxic to HTMC.
Key Words: Bevacizumab;Nitric oxide;Trabecular meshwork cells


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next